Вы искали: incidensrater (Датский - Английский)

# rr af incidensrater for hver 100 patientår
# rr of incidence rates per 100 patient years

resumé af incidensrater for potentielle tasmarbivirkninger fra fase iii placebokontrollerede undersøgelser:
summary of potentially tasmar-related adverse reactions, with crude incidence rates for the phase iii placebo-controlled studies:

beskrivelse og håndtering af neutropeni og trombocytopeni, herunder incidensrater fra kliniske studier
description and management of neutropenia and thrombocytopenia including incidence rates from clinical trials

beskrivelse af risikoen for progression til aml hos patienter med mds, herunder incidensrater fra kliniske studier
description of the risk of progression to aml in mds patients including incidence rates from clinical trials

beskrivelse og håndtering af tromboemboli-risikoen, herunder incidensrater fra kliniske studier og erfaring efter markedsføring
description and management of thromboembolic risk including incidence rates from clinical trials and post-marketing experience

hyppigheden for bivirkningerne klassificeret i nedenstående tabel omfatter incidensrater observeret ved sammenlægning af fem studier af 24 ugers varighed og i sikkerhedsstudiet af 12 måneders varighed.
the frequencies assigned to the adverse reactions identified in the table below include crude incidence rates observed in the integration of five 24-week studies and in the 12-month safety study.

i enkeltdosisundersøgelser med frivillige forsøgspersoner med doser op til 800 mg er bivirkningerne de samme, som ses efter lavere doser, men incidensrater og sværhedsgrader er forhøjede.
in single dose volunteer studies of doses up to 800 mg, adverse reactions were similar to those seen at lower doses, but the incidence rates and severities were increased.

de poolede data fra disse 18 studier viser sammenlignelige incidensrater for de enkelte kategorier af psykiatriske bivirkninger hos de patienter, der blev behandlet med vareniclin, sammenlignet med de patienter, fik placebo.
pooled data from these 18 trials showed a similar incidence rate of individual categories of psychiatric events in patients treated with varenicline compared to patients treated with placebo.

hyppigheden af bivirkningerne anført i nedenstående tabel omfatter incidensrater observeret i fire effektstudier og et længerevarende sikkerhedsstudie (som omfattede 1.412 patienter, der fik umeclidiniumbromid).
the frequencies assigned to the adverse reactions identified in the table below include crude incidence rates observed from four efficacy studies and the long-term safety study (which involved 1,412 patients who received umeclidinium bromide).

i kliniske forsøg med 1.784 patienter i behandling med axura for mild til svær demens og med 1.595 patienter i placebobehandling adskilte den generelle incidensrate for bivirkninger med axura sig ikke fra placebobehandlingen, og bivirkningerne var som regel milde til moderate.
in clinical trials in mild to severe dementia, involving 1,784 patients treated with axura and 1,595 patients treated with placebo, the overall incidence rate of adverse reactions with axura did not differ from those with placebo; the adverse reactions were usually mild to moderate in severity.